期刊
CANCER CELL
卷 20, 期 6, 页码 797-809出版社
CELL PRESS
DOI: 10.1016/j.ccr.2011.11.014
关键词
-
资金
- Dutch Cancer Society [NKI 2007-3772, NKI 2008-4116]
- Cancer Systems Biology Center
- Netherlands Organization for Scientific Research (NWO)
- MRC [G6900577]
- Breast Cancer Campaign [SF06]
- NWO [VIDI-91711302]
- MRC [G9600577] Funding Source: UKRI
- Medical Research Council [G9600577] Funding Source: researchfish
Hereditary breast cancers are frequently caused by germline BRCA1 mutations. The BRCA1(C61G) mutation in the BRCA1 RING domain is a common pathogenic missense variant, which reduces BRCA1/BARD1 heterodimerization and abrogates its ubiquitin ligase activity. To investigate the role of BRCA1 RING function in tumor suppression and therapy response, we introduced the Brca1(C61G) mutation in a conditional mouse model for BRCA1 -associated breast cancer. In contrast to BRCA1 -deficient mammary carcinomas, tumors carrying the Brca1(C61G) mutation responded poorly to platinum drugs and PARP inhibition and rapidly developed resistance while retaining the Brca1(C61G) mutation. These findings point to hypomorphic activity of the BRCA1-C61G protein that, although unable to prevent tumor development, affects response to therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据